Business
GREY WOLF ANIMAL HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
GREY WOLF ANIMAL HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERE...
About this update from Grey Wolf Animal Health Corp
[{"type":"text","content":"\n \n \n \n GREY WOLF ANIMAL HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n GREY WOLF ANIMAL HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE\n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n April 2, 2024\n \n \n /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF) (\"Grey Wolf\" or the \"Company\"), a Canadian diversified animal health company, today announced that\n \n Angela Cechetto\n \n , CEO, is scheduled to present a corporate update at the 2024 Bloom Burton & Co. Healthcare Investor Conference on\n \n Wednesday April 17, 2024\n \n at\n \n 3:00pm ET\n \n at the Metro Toronto Convention Centre in\n \n Toronto\n \n .\n \n \n \n \n \n \n \n \n \n Grey Wolf management will also be available for one-on-one meetings during both days of the conference to be held on\n \n April 16-17\n \n , 2024.  Investors interested in meeting with Grey Wolf during the conference should contact the conference coordinator or email\n \n [email protected]\n \n .\n \n \n \n About Grey Wolf Animal Health Corp.‎\n \n \n \n Grey Wolf Animal Health Corp., headquartered in\n \n Toronto, Canada\n \n , is a diversified animal health ‎company founded by a veterinarian to bring to market a broad portfolio of products that meets the ‎unmet needs of veterinarians, clinics and pets.  The Company's strategy is to in-license, acquire or develop innovative prescription and non-prescription products for commercialization in the veterinarian channel ‎in\n \n Canada\n \n . For additional information, please visit:\n \n www.greywolfah.com\n \n .‎\n \n \n Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.\n \n \n \n Forward Looking Statements\n \n \n \n \n This news release includes certain statements that may be deemed \"forward-looking statemen...